Hsu PI, Jwo JJ, Tseng HH, Lai KH, Lo GH, Lo CC, Wu CJ, Chuah SK, Hwang IR, Chen JL, Chen YS, Chen A. Association of the myeloperoxidase-468G→A polymorphism with gastric inflammation and duodenal ulcer risk. World J Gastroenterol 2005; 11(18): 2796-2801 [PMID: 15884126 DOI: 10.3748/wjg.v11.i18.2796]
Corresponding Author of This Article
Angela Chen, PhD, Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 80424, Taiwan, China. achen@mail.nsysu.edu.tw
Article-Type of This Article
Brief Reports
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Ping-I Hsu, Kwok-Hung Lai, Gin-Ho Lo, Ching-Chu Lo, Chung-Jen Wu, Yu-Shan Chen, Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, National Yang-Ming University, Kaohsiung, Taiwan, China
Hui-Hwa Tseng, Department of Pathology, Kaohsiung Veterans General Hospital, National Yang-Ming University, Kaohsiung, Taiwan, China
Seng-Kee Chuah, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan, China
Il-Ran Hwang, Department of Internal Medicine, Dankook University Hospital, South Korea
Jin-Liang Chen, Department of Health Care and Hospital Administration, Chia-Nan University of Pharmacy and Science, Tainan, Taiwan, China
Jyh-Jen Jwo, Angela Chen, Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan, China
ORCID number: $[AuthorORCIDs]
Author contributions: All authors contributed equally to the work.
Supported by the grants from the Research Foundation of Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, China VGHKS92-74 and the National Science Council, Taiwan, China NSC-92-2314-B-075B-006
Correspondence to: Angela Chen, PhD, Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 80424, Taiwan, China. achen@mail.nsysu.edu.tw
Telephone: +886-7-5255815 Fax: +886-7-5255816
Received: November 2, 2004 Revised: November 3, 2004 Accepted: November 23, 2004 Published online: May 14, 2005
Abstract
AIM: To elucidate the relations between the myeloperoxidase-468G→A polymorphism and the development of duodenal ulcer (DU), and to investigate the impacts of this host genetic polymorphism on the histopathological features of Helicobacter pylori (H pylori)-related gastritis.
METHODS: In a case-control study of 115 consecutive DU patients and 182 controls, the myeloperoxidase-468G→A polymorphism was genotyped. Additionally, gastric mucosal changes were examined according to the updated Sydney System.
RESULTS: The two study groups differed in the distributions of myeloperoxidase genotypes (P = 0.008). All six individuals carrying myeloperoxidase A/A genotypes were in the DU group. The carriage of myeloperoxidase allele A and H pylori infection were associated with an increased risk of DU with odds ratios (OR) of 2.3 and 5.8, respectively. The combined risk of the carriage of myeloperoxidase allele A and H pylori infection for DU was 8.7 (95% CI, 3.5-21.8). In the H pylori-infected individuals, allele A carriers displayed higher bacterial density scores (P = 0.04) in the antrum than did non-carriers.
CONCLUSION: This work verifies for the first time the association of myeloperoxidase-468G→A polymorphism with antral H pylori density and DU disease. The mechanisms underlying this genetic polymorphism in developing DU disease merit further investigations.
Citation: Hsu PI, Jwo JJ, Tseng HH, Lai KH, Lo GH, Lo CC, Wu CJ, Chuah SK, Hwang IR, Chen JL, Chen YS, Chen A. Association of the myeloperoxidase-468G→A polymorphism with gastric inflammation and duodenal ulcer risk. World J Gastroenterol 2005; 11(18): 2796-2801
The discovery of Helicobacter pylori (H pylori)heralded a breakthrough in the field of gastroenterology. It is a well-recognized pathogen that chronically infects more than 50% of the world’s population. Infection with the bacterium regularly leads to chronic gastritis. A subset of infected patients develops duodenal ulcer (DU), gastric ulcer, gastric adenocarcinoma and mucosa-associated lymphoid tissue lymphoma (MAL-Toma)[1-4]. The course of disease is affected by bacterial virulence factors, as well as genetic predisposition and environmental factors of the hosts.
It has been suggested that phenotypic or genotypic differences of the cag pathogenicity island, vacA, iceA and babA among bacterial strains may account for the development of severe diseases[5-8]. Early studies indicated that the cagA gene/CagA protein was a marker for more severe diseases because it was more frequently associated with strains isolated from patients with ulcer diseases or gastric adenocarcinoma[5,6]. However, the predominant strain of H pylori that circulates in Asian countries is a cagA-positive, vacA s1 and babA2 genotype, unrelated to clinical outcomes[9,10]. Bacterial virulent factors have so far failed to explain why the ulcer or gastric cancer phenotype develops[11,12]. Recently, attention has been focused on the involvement of host factors that determine susceptibility to H pylori-associated diseases, such as gender, blood groups, gastric acid physiology, human leukocyte antigen and genetic polymorphisms[13-15].
It is well known that H pylori infection is characterized by extensive infiltration of neutrophils. Neutrophils may generate superoxide anion (O2-), hydroxyl radical (∙OH) and nonradical oxidants, such as hypochlorous acid (HOCl), to kill invading micro-organisms[16-18]. Myeloperoxidase is an important enzyme of neutrophils. It is the key enzyme for the formation of HOCl from H2O2 in the presence of chloride ions. HOCl is a potent oxidant known to have several cytotoxic effects on bacterial cells. The integrity of bacterial cell membrane may be violated by the oxidation of membrane proteins[17]. Additionally, activated neutrophils and monocytes can also generate cytotoxic chloramines, tyroxyl radicals, and ∙OH via an myeloperoxidase-dependent pathway[16,18].
The inter-individual variations in myeloperoxidase activity of neutrophils are genetically determined[19]. A diallelic polymorphism at the promoter region of myeloperoxidase gene (-463 bp) was observed, and is related to the transcription activity of this gene[20]. The G allele is the wild type with normal expression, while the A allele is a low-expression allele[20]. Recently, Roe et al[21], disclosed that myeloperoxidase genotype critically determines the pathogenesis of atrophic gastritis subsequent to H pylori infection. However, no data exist regarding the relationships between myeloperoxidase genotype and peptic ulcer disease. The purposes of this study were to elucidate the relations between the myelope-roxidase-468G→A polymorphism and the development of DU, and to investigate the impacts of this host genetic polymorphism on the histopathological features of H pylori-related gastritis.
MATERIALS AND METHODS
Subjects
One hundred and fifteen consecutive unrelated Taiwanese with DU, who attended the Kaohsiung Veterans General Hospital, were included in this study. The diagnosis of DU was confirmed by endoscopic examination. An ulcer was defined as a circumscribed mucosal break 5 mm or more in diameter, with a well-defined ulcer crater. The size of ulceration was measured by opening a pair of biopsy forceps of known span in front of the ulcer. One hundred and eighty-five consecutive ethically matched asymptomatic healthy volunteers without active or past DU history served as healthy controls (HCs), and their endoscopic findings were all normal or showed gastritis only. The asymptomatic controls were enrolled from our health examination clinics. For them, panendoscopy was a routine examination of the general health checkup because the gastric cancer incidence was high in our country. To minimize ethnic bias, all patients and controls were Han Chinese; aboriginal and alien populations were excluded. Exclusion criteria for both groups included (1) history of esophageal or gastric ulcer, (2) previous history of anti-H pylori therapy, (3) use of non-steroidal anti-inflammatory drug or proton pump inhibitors within one month of endoscopy, (4) associated gastrointestinal malignancy, and (5) serious medical illness. To adjust clinical characteristics, the following data were recorded for each subject: age, sex, blood type, smoking history and alcohol consumption. The study was approved by the Medical Research Committee of the Kaohsiung Veterans General Hospital. All patients and controls gave informed consent.
Study design
Endoscopies were performed with the Olympus GIF XV10 and GIF XQ200 (Olympus Corp., Tokyo, Japan). During endoscopy, biopsies over antrum were performed for rapid urease test and histological examination. Prior to endoscopy, venous blood was drawn for serological test and myeloperoxidase genotyping. Serology was studied using a commercial IgG EIA kit (Premier H pylori; Meridian Diagnostics Inc., Cincinnati, OH). The diagnosis of H pylori infection was based on at least two positive results of histological findings, rapid urease test and serological assay.
To assess the significance of clinical characteristics, the following data were recorded for each patient: age, sex, blood type, smoking and alcohol consumption.
Histology
A histological examination of stomach was carried out during endoscopy for the subjects who provided informed consent for topographic histopathological study. Two specimens were taken from the antrum (pyloric gland area) and corpus (fundic gland area) at standard topographic sites. The biopsy specimens were fixed in 10% buffered formalin, embedded in paraffin, and sectioned. The sections were stained with a hematoxylin and eosin stain and a modified Giemsa stain as previously described[22,23]. Sections were examined blinded to the patient’s clinical diagnosis. Scores of acute inflammation (neutrophil infiltration), chronic inflammation (mononuclear cell infiltration), glandular atrophy, intestinal metaplasia and H pylori density were graded from 0 to 3 as described by the updated Sydney system[24].
Rapid urease test
The rapid urease test was performed according to our previous studies[25]. Each biopsy specimen was placed immediately in 1 mL of a 10% solution of urea in deionized water (pH 6.8) to which two drops of 1% phenol red solution had been added and incubated at 37 °C for up to 24 h. If the yellowish color around the area of inserted specimen was changed to bright pink within the 24-h limit, the urease test was considered positive. In our laboratory, the sensitivity and specificity of the rapid urease test were 96% and 91%, respectively[26].
Myeloperoxidase genotyping
Genomic DNA was extracted from 3 mL of whole blood by the use of a QIAamp DNA Extraction Mini Kit (QIAGEN Inc., Valencia, CA). The myeloperoxidase polymorphism analysis was performed using a PCR-restriction fragment length polymorphism method[19]. The primers set to detect the polymorphic site at position -463 were forward primer 5’-CCGTATAGGCAGAGAATGGTGAG-3’ and reverse primer 5’-GCAATGGTTCAAGCGATTCTTC-3’. The PCR product was then digested with AciI and separated on a 2% agarose gel. Individuals homozygous for the G allele had three bands at 169, 120 and 61 bp, whereas those heterozygous alleles, myeloperoxidase (G/A), had four bands at 289, 169, 120 and 61 bp. Individuals homozygous for the A allele had two bands at 61 and 289 bp.
Statistical analysis
Statistical evaluations were performed using the SPSS/Windows computer software package (Chicago, IL). Two-sample t-tests were used to compare the mean values of the variables considered continuous in the DU patients and HCs. The χ2 test with or without Yate’s correction for continuity and Fisher’s exact test when appropriate were applied to analyze the categorized variables. Differences were considered to be significant at P<0.05. A multivariate analysis with logistic regression method was carried out to assess the odds ratios (ORs) of the risk factors of DU. The studied variables included the following: age (<60 or ≥60 years), sex, blood type (O type or non-O type), history of smoking (<1 or ≥1 pack/wk), history of alcohol consumption (<80 or ≥80 g/d), H pylori status (presence or absence) and the carriage of myeloperoxidase allele A (yes or no).
We estimated that a 20% difference in the susceptible factor could be present in DU patients and HCs. Based on this assumption, 95 subjects had to be studied in each group to yield a statistical power of 0.80 and an α value of 0.05.
RESULTS
Characteristics of the patients
Table 1 shows the demographic characteristics of DU patients and controls. Patients with DU were more likely to be males and to smoke than the HCs (P = 0.012 and 0.014, respectively). The infection rate was significantly higher in the DU group than in the control group (P<0.001). The two groups were similar with respect to age, blood type and history of alcohol consumption.
Table 2 displays the distribution of myeloperoxidase genotypes in study groups. The distributions of this myeloperoxidase polymorphism were distinctively different between groups (P = 0.008). The G/G, G/A and A/A genotypes were 79%, 21% and 0% respectively in HCs, and 73%, 22% and 5% respectively in DU patients. All six individuals carrying myeloperoxidase A/A genotypes were in the DU group (myeloperoxidase A/A genotype: DU, 5%; HCs, 0%; P = 0.003).
Table 2 Genotypes and allele frequencies of myeloperoxidase gene in DU patients and HCs (n, %).
HCs (n = 182)
DU (n = 115)
P
Genotypes
0.008
G/G
143 (78.6)
84 (73.0)
G/A
39 (21.4)
25 (21.7)
A/A
0 (0.0)
6 (5.2)
Combined risk of myeloperoxidase polymorphism and H pylori-infection for the development of DU
Table 3 presents the carriage rate of myeloperoxidase allele A and the H pylori status in the two studied groups. The carriage of myeloperoxidase allele A and H pylori infection were associated with an increased risk of DU with OR of 2.3 [95%CI, 0.8-8.4] and 5.8 (95%CI, 2.9-11.8), respectively. The combined risk of the carriage of myeloperoxidase allele A and H pylori infection for DU was 8.7 (95%CI, 3.5-21.8).
Table 3 The myeloperoxidase polymorphism and H pylori infection in the development of DU.
Myeloperoxidaseallele A carrier
H pylori infection
HC (n = 182, %)
DU (n = 115, %)
Odds ratio1(95%CI)
P
(-)
(-)
72 (39.6)
13 (11.3)
-
(+)
(-)
23 (12.6)
9 (7.8)
2.3 (0.8-8.4)
0.1257
(-)
(+)
71 (39.0)
71 (61.7)
5.8 (2.9-11.8)
<0.001
(+)
(+)
16 (8.8)
22 (19.1)
8.7 (3.5-21.8)
<0.001
Comparison of histological gastritis between DU patients and HCs
Table 4 lists the histological gastritis scores in the antrum and the corpus. The scores of bacterial density, activity, inflammation, glandular atrophy and numbers of lymphoid follicles in the antrum were significantly higher in DU patients than in HCs (P = 0.010, 0.002, 0.002, 0.001 and 0.040, respectively). The DU patients also had higher H pylori densities, activity and inflammation scores in the corpus compared with HCs (P = 0.025, 0.021 and 0.003, respectively).
Table 4 Comparison of gastric histological findings between DU patients and HCs.
Impact of the host myeloperoxidase genotypes on H pylori-related gastritis
The relationships between H pylori infection and the severity of gastritis were examined in this study. In the antrum, the activity, inflammation and atrophy scores and the number of lymphoid follicles were markedly higher in the H pylori-infected individuals than in the non-infected individuals (1.83±0.11 vs 0.18±0.10, 2.88±0.06 vs 1.24±0.20, 1.21±0.11 vs 0.29±0.17, and 0.57±0.12 vs 0.00±0.00, respectively; P<0.001, P<0.001, P<0.001 and P=0.004, respectively). The H pylori-infected individuals also had higher activity, inflammation and atrophy scores in the corpus than the H pylori-negative individuals (0.83±0.13 vs 0.06±0.06, 2.05±0.11 vs 1.25±0.14 and 0.26±0.08 vs 0.00±0.00; P<0.001, P<0.001 and P = 0.041).
Figure 1 shows how the host myeloperoxidase genotypes impact H pylori-related gastritis. Amongst the H pylori-infected individuals, the myeloperoxidase allele A carriers had higher scores of H pylori densities in the antrum than the non-carriers (2.00±0.17 vs 1.52±0.14, P = 0.044). Additionally, the myeloperoxidase allele A carriers also showed a trend towards greater numbers of lymphoid follicles in the antrum and corpus than non-carriers (antrum: 0.87±0.22 vs 0.41±0.14, P = 0.074; corpus: 0.20±0.11 vs 0.04±0.04, P = 0.089).
Figure 1 Impact of host myeloperoxidase genotypes on H pylori-related gastritis.
DISCUSSION
The current study found that the myeloperoxidase-468G→A polymorphism was significantly associated with DU disease. The G/G, G/A and A/A genotypes were 79%, 21% and 0%, respectively in HCs and 73%, 22% and 5%, respectively in DU patients. The two study groups differed in myeloperoxidase genotype distributions. Interestingly, the six individuals carrying myeloperoxidase A/A genotype were in the DU group. None of the 185 HCs had this special genotype. Another study by Roe et al[21], also showed no myeloperoxidase A/A genotype present in 127 Korean gastritis patients. Recently, we have examined the myeloperoxidase genotypes of 269 gastric cancer patients, and none of them had the A/A genotypes (unpublished data). These results, taken together, suggest that the individuals carrying myeloperoxidase A/A genotype are prone to develop DU.
Myeloperoxidase is an important enzyme of neutrophils, related to oxidant burst for bacterial killing. Neutrophils are one of the professional phagocytes in humans. They manufacture O2- by the one-electron reduction of oxygen at the expense of NADPH[8,16,27]. Most of the O2- reacts with itself to form H2O2. From these agents a large number of highly reactive microbicidal oxidants are formed, including HOCl, ∙OH, peroxynitrite and many others[28]. Uniquely, myeloperoxidase readily oxidizes chloride ions to the strong nonradical oxidant, HOCl, which have several cytotoxic effects on bacterial cells[27-30]. Recent reports demonstrated that myeloperoxidase activity of neutrophils is genetically determined[19,20]. A G-to-A substitution polym-orphism in the promoter region of myeloperoxidase gene has been suggested to decrease gene transcription due to the disrupted SP1 binding site[20], meaning less enzyme would be available to form HOCl. In our histological study, H pylori-infected allele A carriers had higher scores of bacterial density. This phenomenon may be caused by low myelope-roxidase activity in the allele A carriers, whose neutrophils had decreased ability to generate HOCl and other reactive oxygen species for bacterial killing[16,30].
Recent studies suggested that the bacterial load is one of the determinants related to the outcomes of H pylori-infected individuals. Bacterial densities of DU patients were significantly higher than those of gastritis patients[31,32]. In addition, the higher the H pylori load, the worse the associated gastritis[33]. Recently, Richter-Dahlfors et al[33], demonstrated that co-culture of antral epithelial cells with H pylori increased basal gastrin secretion of epithelial cells. Furthermore, Talamini et al[34], disclosed that high H pylori density was an independent risk factor of DU. We therefore propose that the H pylori-infected individuals with high bacterial loads may stimulate more antral gastrin release, which can lead to excessive acid secretion from the corpus and result in DU diathesis.
H pylori infection is widely accepted as the most important factor in the pathogenesis of DU and MALToma. In our histological studies, the H pylori-infected individuals displayed higher scores of activity, inflammation and gland atrophy in both antrum and body than the non-infected individuals. The H pylori-infected individuals who carried the myeloperoxidase allele A had higher bacterial scores in the antrum and a trend towards increased lymphoid follicles in the antrum and corpus than infected non-carriers (P = 0.074 and 0.089 respectively). Currently, the host factors affecting the growth of mucosa-associated lymphoid tissues and MALToma remain unclear. Whether the low-expression myeloperoxidase genotype is related to the pathogenesis of MALToma deserves further study.
The major paradox in H pylori research is the apparent association of the infection with divergent and mutually exclusive clinical outcomes[11,13]. The infection increases the risk of DU, a condition characterized by antral-predominant gastritis and high acid secretion while also heightening the risk of gastric cancer, a condition characterized by corpus-predominant gastritis and hypochlorhydria. Roe et al[21], revealed that myeloperoxidase genotype is a critical determinant in the pathogenesis of atrophic gastritis subsequent to H pylori infection. A strong positive correlation between the levels of gastric atrophy was found in wild myeloperoxidase (G/G) genotype but not in low expression (G/A) genotype. This implies that wild myeloperoxidase genotype is linked with gastric carcinogenesis. Interestingly, we observed that the carriage of myeloperoxidase allele A is related to the development of DU disease. Aforementioned studies suggest that myeloperoxidase genotype may be a critical turning factor for the outcomes of H pylori-infected individuals.
To our knowledge, this study is the first to verify the association of myeloperoxidase-468G→A polymorphism with DU disease. The H pylori-infected allele A carriers had higher bacterial load in the antrum than did infected non-carriers. More work is mandatory to clarify the relationship between low-expression myeloperoxidase genotype, the reactive oxygen species of neutrophils and the fates of H pylori-infected individuals.
ACKNOWLEDGMENTS
The authors express their deep appreciation to Dr. Lung-Chih Cheng, Chao-Ming Wu, Hsien-Chung Yu, Chung-Jen Wu and Miss Pei-Min Tsai for their generous support.
Hsu PI, Lai KH, Lo GH, Tseng HH, Lo CC, Chen HC, Tsai WL, Jou HS, Peng NJ, Chien CH. Risk factors for ulcer development in patients with non-ulcer dyspepsia: a prospective two year follow up study of 209 patients.Gut. 2002;51:15-20.
[PubMed] [DOI][Cited in This Article: ][Cited by in Crossref: 43][Cited by in F6Publishing: 46][Article Influence: 2.1][Reference Citation Analysis (0)]
Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN, Nomura A. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach.Cancer Res. 1995;55:2111-2115.
[PubMed] [DOI][Cited in This Article: ]
Yamaoka Y, Kodama T, Gutierrez O, Kim JG, Kashima K, Graham DY. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries.J Clin Microbiol. 1999;37:2274-2279.
[PubMed] [DOI][Cited in This Article: ]
Hampton MB, Kettle AJ, Winterbourn CC. Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing.Blood. 1998;92:3007-3017.
[PubMed] [DOI][Cited in This Article: ]
Le Marchand L, Seifried A, Lum A, Wilkens LR. Association of the myeloperoxidase -463G--& gt; a polymorphism with lung cancer risk.Cancer Epidemiol Biomarkers Prev. 2000;9:181-184.
[PubMed] [DOI][Cited in This Article: ]
Roe I, Nam S, Kim J, Shin J, Bang W, Yang M. Association of the myeloperoxidase -463G--& gt; A polymorphism with development of atrophy in Helicobacter pylori-infected gastritis.Am J Gastroenterol. 2002;97:1629-1634.
[PubMed] [DOI][Cited in This Article: ]
Zverkov IV, Isakov VA, Aruin LI. Helicobacter pylori, endocrine cells of the gastric mucosa, and their function in duodenal ulcer.Arkh Patol. 1996;58:33-37.
[PubMed] [DOI][Cited in This Article: ]
Plebani M, Basso D, Cassaro M, Brigato L, Scrigner M, Toma A, Di Mario F, Rugge M. Helicobacter pylori serology in patients with chronic gastritis.Am J Gastroenterol. 1996;91:954-958.
[PubMed] [DOI][Cited in This Article: ]
